Brief: Galecto Announces Pricing Of $275 Million Underwritten Public Offering
11/02/2026 03:43
Feb 10 (Reuters) - Galecto Inc GLTO.O: GALECTO ANNOUNCES PRICING OF $275 MILLION UNDERWRITTEN PUBLIC OFFERING GALECTO INC - SELLING 14,473,685 SHARES AT $19.00 PER SHARE Source text: ID:nGNX9dVf78 Further company coverage: GLTO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing